PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 354392

Ocular cryptococcosis.

J Avendaño·T Tanishima·T Kuwabara
View original source ↗Export metadata ↓

Abstract

We studied ocular cryptococcosis in a 59-year-old man who had received extensive chemotherapy for abdominal malignant lymphoma. Mucinous lesions containing abundant cryptococci, but no inflammatory cells, formed in the posterior choroid of the eye. Electron microscopy revealed that mucin, a filamentous substance, coated the encapsulated organisms. Except for a few degenerating ones in histiocytes, most cryptococci appeared in the extracellular space.

Explore related subjects

Antineoplastic AgentsChoroidCryptococcosisCryptococcusHumansLymphoma, Large B-Cell, DiffuseMaleMiddle AgedUveal DiseasesCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Avendaño, T Tanishima, T Kuwabara. 1978. Ocular cryptococcosis.. https://doi.org/10.1016/0002-9394(78)90025-9

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2021

Deep generative neural network for accurate drug response imputation.

Drug response differs substantially in cancer patients due to inter- and intra-tumor heterogeneity. Particularly, transcriptome context, especially tumor microenvironment, has been shown playing a significant role in shaping the actual treatment outcome. In this study, we develop a deep variational autoencoder (VAE) model to compress thousands of genes into latent vectors in a low-dimensional space. We then demonstrate that these encoded vectors could accurately impute drug response, outperform standard signature-gene based approaches, and appropriately control the overfitting problem. We apply rigorous quality assessment and validation, including assessing the impact of cell line lineage, cross-validation, cross-panel evaluation, and application in independent clinical data sets, to warrant the accuracy of the imputed drug response in both cell lines and cancer samples. Specifically, the expression-regulated component (EReX) of the observed drug response achieves high correlation across panels. Using the well-trained models, we impute drug response of The Cancer Genome Atlas data and investigate the features and signatures associated with the imputed drug response, including cell line origins, somatic mutations and tumor mutation burdens, tumor microenvironment, and confounding factors. In summary, our deep learning method and the results are useful for the study of signatures and markers of drug response.

Antineoplastic Agents↗